Wnt signaling in triple negative breast cancer is associated with metastasis
about
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsWnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approachesAHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.Pathway-based analysis of breast cancer.Rapid estrogen signaling negatively regulates PTEN activity through phosphorylation in endometrial cancer cells.MYC-xing it up with PIK3CA mutation and resistance to PI3K inhibitors: summit of two giants in breast cancersEnriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs.Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma.β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesMEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.PINTnet: construction of condition-specific pathway interaction network by computing shortest paths on weighted PPI.IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumorsAnti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers.YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis through interaction with β-catenin.Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-nessRAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer.Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.3'UTR shortening and EGF signaling: implications for breast cancer.Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion.Cell lineage determinants as regulators of breast cancer metastasis.Wnt signaling in triple-negative breast cancer.Medulloblastoma: Molecular Classification-Based Personal Therapeutics.Cancer cells remodel themselves and vasculature to overcome the endothelial barrier.ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.Improved prediction of breast cancer outcome by identifying heterogeneous biomarkers.ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer.Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells.
P2860
Q26773795-657C6D58-00F9-42F3-BD65-3D38CD174486Q28077396-991528DD-36AE-454B-93AD-79F3B9AE73D3Q33667940-393BFB0F-6643-4DE8-BBF3-1FEB659BD25AQ33758011-9330DB00-6541-41C8-88E5-063DF0905035Q33921596-3591DBA6-907A-4729-B4DA-7E4AC1736398Q34991267-7FA62BD2-061E-422B-B7B3-ACCBFC276A5EQ35620990-10021B05-01C2-4A02-859C-7CC6AD670B7DQ35753592-321FBB0B-1CA5-4597-9053-79D54DBF5A40Q35930626-483618B3-D893-43F3-B03B-3D7C6041D750Q36157045-AD93852E-1DD2-4489-9A46-2C4CB4A4FB1CQ36258723-00CBC92D-C814-4185-BD2E-7B3859F2E2B0Q36329423-30230325-4F73-4085-9A2F-094EDC272EFCQ36664343-85AE03A1-4BE5-4AC4-A518-4C1E600C766FQ36879470-575E5C2E-D3AD-43C7-9D31-68A4B6B62E10Q37085002-CD58F7C0-00F3-44CB-A830-924B2055E3FFQ37258950-133799E5-8F17-4B58-A5FE-3A2431CECA57Q37397989-DE6AFC68-4673-45F3-9589-0ED509031D9FQ37536500-4A09A43F-9C5A-4EEB-82C6-51F37131EC6BQ37584321-612A53A0-D361-4908-8C04-CEEC4A6B79B5Q37709429-E9A3A530-B3CB-4083-AD54-4FE47704186EQ37716574-3CA698AE-98CC-4110-9C57-26AE4A77B6BFQ37722121-B66D870B-1727-410E-AEE8-12762B121E63Q37736204-ECCF13B3-DBFE-4DBD-891D-4EA66669E3DEQ38648429-1A6F1551-424B-45F1-9D95-7C6D45598114Q38696301-CF42200D-C91A-4726-97F7-EE27A626B84CQ38748855-A035049F-C7C2-4218-8A66-673624350DB9Q38833441-2DEB2E3B-622B-4D99-AA3B-2BCB78F9826CQ38936102-A45A59E7-3386-4C68-9B24-B7C81ED03D2CQ39014552-43F94965-6B89-45C1-B1BD-517929787CD1Q39214992-415146C1-B693-4094-BE3B-5CC8A7299DC6Q39225738-2C325AAE-A306-485B-9ABE-2C6BB44926A1Q41636608-17771E6F-3F39-4A9A-85B5-A5EBC51F6446Q41674321-1027105E-9631-4C0E-BEFB-8E3DCF5E42C9Q42334209-588D48D2-C9FF-4724-AECB-081A2A3CAB5FQ42374136-DD3BADE1-11C3-4B77-847B-678218E9B5A0Q42696721-A2242582-0199-4D25-AB5C-8D55B62E5397Q45762115-01C550DC-9CF7-49E5-90B5-31FC2D78D6DEQ45786900-BCBDE344-D5DE-4CF7-8904-87E009FD15EEQ46164259-F9BA4891-66E6-490E-87A5-7693AF416856Q47114871-E5F8F000-0BC9-46DB-B00D-004E4321FB63
P2860
Wnt signaling in triple negative breast cancer is associated with metastasis
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Wnt signaling in triple negative breast cancer is associated with metastasis
@ast
Wnt signaling in triple negative breast cancer is associated with metastasis
@en
type
label
Wnt signaling in triple negative breast cancer is associated with metastasis
@ast
Wnt signaling in triple negative breast cancer is associated with metastasis
@en
prefLabel
Wnt signaling in triple negative breast cancer is associated with metastasis
@ast
Wnt signaling in triple negative breast cancer is associated with metastasis
@en
P2093
P2860
P50
P356
P1433
P1476
Wnt signaling in triple negative breast cancer is associated with metastasis
@en
P2093
Brian R Leyland-Jones
Charles Catzavelos
Gabriella Oprea-Ilies
George W Sledge
Kimberly F Kerstann
Maja Ordanic-Kodani
Mark Abramovitz
Mark Bouzyk
Nandini Dey
P2860
P2888
P356
10.1186/1471-2407-13-537
P407
P577
2013-11-10T00:00:00Z
P5875
P6179
1064133302